Premium
FIRST‐LINE ADJUVANT RADIOTHERAPY IMPROVES PFS IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA ‐ A RETROSPECTIVE ANALYSIS OF 102 PATIENTS FROM A SINGLE CENTER
Author(s) -
Salek D.,
Janikova A.,
Michalka J.,
Miculkova E.,
Hadrabova M.,
Folber F.,
Kral Z.,
Mayer J.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.134_2631
Subject(s) - medicine , rituximab , radiation therapy , regimen , single center , population , chemotherapy regimen , oncology , surgery , lymphoma , chemotherapy , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom